tradingkey.logo

ASP Isotopes Inc

ASPI
View Detailed Chart

8.930USD

-0.140-1.54%
Close 08/01, 16:00ETQuotes delayed by 15 min
643.57MMarket Cap
LossP/E TTM

ASP Isotopes Inc

8.930

-0.140-1.54%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.54%

5 Days

-14.71%

1 Month

+27.94%

6 Months

+55.30%

Year to Date

+97.13%

1 Year

+313.43%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts
BUY
Current Rating
7.750
Target Price
-13.21%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

173
Total
5
Median
8
Average
Company name
Ratings
Analysts
ASP Isotopes Inc
ASPI
2
Biogen Inc
BIIB
37
Vertex Pharmaceuticals Inc
VRTX
34
Alnylam Pharmaceuticals Inc
ALNY
34
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
1
2
3
...
35

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(5)
Neutral(3)
Buy(4)
Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.114
Neutral
RSI(14)
51.566
Neutral
STOCH(KDJ)(9,3,3)
20.455
Sell
ATR(14)
0.983
High Vlolatility
CCI(14)
-66.645
Neutral
Williams %R
57.974
Sell
TRIX(12,20)
1.145
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
9.372
Sell
MA10
9.619
Sell
MA20
8.806
Buy
MA50
8.270
Buy
MA100
6.772
Buy
MA200
6.135
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
Ticker SymbolASPI
CompanyASP Isotopes Inc
CEOMr. Paul Elliot Mann
Websitehttps://aspisotopes.com/
KeyAI